Skip to main content
. Author manuscript; available in PMC: 2019 Dec 28.
Published in final edited form as: Mol Pharm. 2019 Feb 15;16(3):1412–1420. doi: 10.1021/acs.molpharmaceut.8b01278

Figure 6.

Figure 6.

Single slice coronal 89Zr-SiR-LDFC-trastuzumab (A) and 89Zr-DFO-trastuzumab (B) PET/CT images in SKOV-3 subcutaneous tumor-bearing mice (n = 4) at 24, 28, 72, and 96 h p.i. Tumor indicated by white arrow.